Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and ...

The Karnataka High Court rejected a plea to transfer the MUDA scam investigation to the CBI, emphasizing independence of the Lokayukta and dismissing claims of bias due to the involvement of a sitting ...

Vaxxas, a clinical-stage biotechnology company, has announced the appointments of three globally respected vaccine experts as ...

It was a busy week for the biotech sector as the fourth-quarter earnings season kicked in. While Regeneron REGN gained following the announcement, Amgen AMGN was in the red. Meanwhile, other pipeline ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

The Compounding Pharmacy Service market is set to exhibit significant growth, driven by the rising prevalence of chronic diseases, personalized medicine ...

This app uses Apple Intelligence to generate custom images on your device. You can choose from a list of suggested prompts, or you can enter your own description of an image and your iPhone will ...

The price of the 2025 GMC Sierra 2500HD / 3500 HD starts at $48,295 and goes up to $94,795 depending on the trim and options. The crew cab with the standard bed remains our Sierra 2500HD ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...